Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Tamara Ghanem

- PMLiVE

ViiV bags EU okay for new two-drug HIV therapy

Rivals Gilead's Biktarvy

- PMLiVE

Boehringer bolsters NASH pipeline with $870m Yuhan deal

Strengthens existing relationship

- PMLiVE

Amicus forms gene therapy manufacturing partnership with Catalent

Biotech invests to speed gene therapies into clinical trials

Patient Centricity on Trial – Trial Patient Focus Group www.patientcentricityontrial.com

Havas Lynx

Patient Centricity on Trial Focus Group Highlights

Havas Lynx

Havas Lynx Group lifts a silver Cannes Lion with landmark HIV campaign

Communicating a landmark moment for the HIV community has helped a leading healthcare communications agency secure another award at the famous Cannes Lions International Festival of Creativity.

Havas Lynx

- PMLiVE

Tiziana joins type 1 diabetes prevention field

Cites potential advantages

- PMLiVE

Biogen bounces back with Spinraza early treatment data

Takes battle to Novartis in youngest patients

- PMLiVE

Sanofi/Regeneron’s IO latecomer Libtayo approved in Europe

Licensed to treat one of the most commonly diagnosed skin cancers

- PMLiVE

Lucid has been celebrating 10 years of professionalism and unwavering passion

Lucid recognises, rewards and celebrates long-term service with flowers, vouchers and additional holiday for those who have been with the company for five and ten years. With over 20% of...

Lucid Group Communications Limited

- PMLiVE

Tecentriq’s triple negative breast cancer use among key CHMP nods

Extensions for AZ drugs, new approval for La Jolla

- PMLiVE

New efficacy data boosts Aimovig’s migraine market lead

Data should help boost uptake

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links